How to Buy Takeda Pharmaceutical Co Stock
Takeda Pharmaceutical Co Ltd
Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products.
Takeda Pharmaceutical Co stock last closed at $18.11, up 0.44% from the previous day, and has increased 19.7% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.5 percentage points. Takeda Pharmaceutical Co stock is currently +39.41% from its 52-week low of $12.99, and -3.77% from its 52-week high of $18.82.
At the moment, there are 1.58B TAK shares outstanding. The market value of TAK is $57.21B. In the last 24 hours, 2.52M TAK shares were traded.
How to Buy Takeda Pharmaceutical Co Stock
Wondering how to invest in Takeda Pharmaceutical Co stock? Here's how.
- Figure out where to buy Takeda Pharmaceutical Co stock: You need to pick a stock brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you figure out where to buy Takeda Pharmaceutical Co stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit funds into your investment account: Select your payment method and add your information.
- Analyze Takeda Pharmaceutical Co stock: The Takeda Pharmaceutical Co ticker symbol is TAK. Is Takeda Pharmaceutical Co stock a good investment? Should you buy shares of TAK? How do TAK's underlying business fundamentals look? Do top analysts think Takeda Pharmaceutical Co is a good buy? Why has TAK's stock price moved recently? (Hint: Our stock research tools can help you figure out if TAK is a good stock to buy).
- Place your TAK purchase: Decide if you will purchase TAK shares at the current market price or use a limit order to purchase TAK stock at a given price.
- Get updates on your investment in TAK: Create a watchlist to keep tabs on your new investment in Takeda Pharmaceutical Co stock.
Step 1: Figure out where to buy Takeda Pharmaceutical Co stock
You will need an online brokerage account in order to access the NYSE market and buy TAK shares.
Our favorite brokerage: eToro
Based on our research, eToro is the best stock brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global financial markets: From Technology to Financial Services, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've chosen the best brokerage, you need to fill out some personal information so you are able to buy TAK today.
How to Set Up a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to open a new brokerage account.
- Send your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've opened your account on the best free stock trading app, you can securely and quickly fund your account:
Check out the walkthrough below for more details depositing money into your investment account.
Step 4: Analyze Takeda Pharmaceutical Co stock
After you have selected the best place to buy Takeda Pharmaceutical Co stock, it's absolutely critical to research their stock prior to investing, so you truly comprehend the risk as well as the upside.
Takeda Pharmaceutical Co Numbers
Takeda Pharmaceutical Co Overview
WallStreetZen was built to help part-time investors perform more in-depth fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on TAK's stock page.
Is TAK stock properly valued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge TAK's intrinsic value.
Using relative valuations measures:
- TAK could be undervalued based on its P/E ratio of 77.06x, relative to Drug Manufacturers - Specialty & Generic industry P/E ratio of -148.56x
- TAK could be undervalued based on its P/B ratio of 1.15x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 1.61x
You can do additional valuation research on TAK's stock here.
TAK Financial Overview
Signs that TAK is financially healthy:
- TAK's operating cash flow of $7.76B allows it to safely service it's debt of $37.16B.
- There are more short-term assets than short-term liabilities on the TAK balance sheet.
- Total TAK debt is lower than 5 years ago, relative to shareholder equity.
Signs that TAK is not financially healthy:
- TAK earnings of $3.72B is not sufficient to cover its interest payments.
- TAK has a relatively high debt to equity ratio of 1.02.
- TAK profit margin has gone down from 4.5% to 2.5% in the past year.
- There are more long-term liabilities than short-term assets on the TAK balance sheet.
TAK Technical Indicators
TAK Performance Metrics
Last year, TAK earnings were $737.40M. During the last 5 year, TAK's earnings have gone up by -16.2% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 9.13%.
Last year, TAK revenue was $29.14B. Over the last five year, TAK's revenue has increased by -1.49% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 6.92%.
Find out more about TAK's earnings and revenue performance here.
Latest Insiders Trades at TAK
In the past year, executives and large shareholders at TAK have not bought or sold any shares.
Research more about who owns TAK shares here.
Can I rely on TAK as an income stream?
No, Takeda Pharmaceutical Co doesn't provide an income stream by paying out dividends.
What others are saying about TAK
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Place your TAK purchase
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are usually fine for most investors. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at an exact dollar amount limit, place a limit order.
Press the Open button and eToro will place your order.
If you require more assistance buying stocks on eToro, click the helpful video below:
Step 6: Get updates on your investment in TAK
Now that you own some TAK stock, you'll want to stay up-to-date on your new investment.
Start a watchlist to track the most important metrics related to your TAK stock.
TAK Feed
How to Buy Stock in Takeda Pharmaceutical Co
To reiterate, here are the 6 steps to buy Takeda Pharmaceutical Co stock:
- Figure out where to buy Takeda Pharmaceutical Co stock
- Create a brokerage account
- Deposit funds into your investment account
- Analyze Takeda Pharmaceutical Co stock
- Place your TAK purchase
- Get updates on your investment in TAK
If you require a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get the latest news on your new investment in Takeda Pharmaceutical Co, create a watchlist on WallStreetZen today.
Other "How To" Guides You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.